Why the Certificate of Analysis Matters
When a vial of synthetic research peptide arrives in your laboratory, the Certificate of Analysis (COA) is the primary document connecting the physical material to the data generated during its manufacture and quality-control testing. Unlike small-molecule compounds, synthetic peptides carry inherent complexity: every additional amino acid residue introduces additional opportunities for incomplete coupling, deprotection side-reactions, racemization, or oxidation. A thorough COA communicates whether the manufacturer has successfully controlled for these variables and provides the objective evidence your laboratory needs to design reproducible experiments.
Reading a COA critically—rather than simply confirming a vial arrived—is an essential laboratory skill. The sections below walk through each standard COA field, explain what the numbers mean, and highlight the red flags that should prompt you to contact your supplier before proceeding.
Identification Fields: Confirming You Have the Right Compound
The top section of any COA carries administrative and chemical identification data. Verify the following before opening the vial:
- Peptide name and sequence: The full single-letter or three-letter amino-acid sequence should be listed explicitly (e.g., Ac-SIINFEKL-NH₂). Compare it character-by-character with your order. N-terminal modifications (acetylation, biotinylation) and C-terminal modifications (amidation, free acid) must be specified precisely, as they alter molecular weight, solubility, and biological activity in cell-based assays.
- Catalog or lot number: This is the traceability anchor. If you need to reorder and replicate a previous experiment, matching lot numbers is preferable; the COA lets you compare analytical data across lots when an exact match is unavailable.
- Molecular formula and molecular weight: Cross-reference the listed molecular weight against a reliable peptide calculator using the stated sequence and modifications. Discrepancies greater than 1–2 Da warrant clarification.
- CAS number (if assigned): Many novel or proprietary research peptides lack a CAS registry number; its absence is not automatically a quality concern, but its presence aids database cross-referencing.
Purity: Understanding HPLC Data
Purity is typically determined by reversed-phase high-performance liquid chromatography (RP-HPLC) with UV detection at 214 nm or 220 nm, wavelengths that absorb the peptide bond rather than individual side-chain chromophores. The reported purity figure represents the percentage of the total UV-integrated area attributable to the main peptide peak.
For most biochemical and cell-based research applications, a purity of ≥95% is considered standard. Work requiring precise stoichiometry—such as isothermal titration calorimetry (ITC), nuclear magnetic resonance (NMR) structural studies, or competitive binding assays with tight-binding ligands—often demands ≥98% purity. Immunological research may accept ≥85% for some antigen-stimulation assays, though this depends on the experimental design and whether impurity profiles are characterized.
Key items to review in the HPLC data block:
- Chromatographic method: Column type (e.g., C18), gradient conditions, and flow rate should be stated. A shallow gradient over a long run time provides higher resolution than a rapid generic gradient and is more likely to reveal closely eluting impurities.
- Retention time: Useful for lot-to-lot comparison when conditions are identical; a drift of more than a few tenths of a minute under identical conditions may indicate structural differences.
- Chromatogram image or area table: Reputable suppliers include the actual chromatogram or a peak-area table. An unnaturally smooth baseline with a single symmetrical peak and no visible minor peaks may indicate data processing artifacts; request raw data if authenticity is uncertain.
Mass Spectrometry: Confirming Molecular Identity
HPLC purity establishes relative proportion but cannot alone confirm molecular identity. Mass spectrometry—most commonly electrospray ionization mass spectrometry (ESI-MS) or matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF)—provides molecular weight confirmation.
On the COA, you will typically see:
- Theoretical monoisotopic or average molecular weight: Calculated from the molecular formula. For peptides below ~2,000 Da, monoisotopic mass is usually reported; above ~3,000 Da, average mass is more common because isotope peaks are not resolved.
- Observed [M+H]⁺ or multiply charged ions: ESI-MS of peptides commonly produces multiply charged ions; the reported m/z value(s) should be reconcilable with the theoretical mass using the formula: M = (m/z × z) − z, where z is the charge state.
- Accepted mass error: A match within ±1 Da (or ±0.1% for larger peptides) is generally acceptable for confirming sequence-consistent identity. Larger discrepancies may indicate sequence errors, unremoved protecting groups, or oxidation artifacts.
Note that mass spectrometry confirms molecular weight consistency with the intended sequence, not absolute structural proof. Sequence isomers (peptides with the same residues in a different order) are indistinguishable by mass alone, which is why the HPLC purity and synthesis records remain important complementary documents.
Additional Analytical Fields
Water Content and Net Peptide Content
Lyophilized peptides absorb atmospheric moisture and may also retain residual trifluoroacetic acid (TFA) or other counter-ions from purification. Some COAs report a net peptide content figure—derived from amino acid analysis (AAA) or quantitative NMR—that corrects for these contributions. When preparing stock solutions for quantitative assays, using the net peptide content rather than total mass yields more accurate concentration estimates.
Counterion Information
RP-HPLC purification using TFA-containing mobile phases results in TFA counter-ions associated with basic residues. TFA is cytotoxic at concentrations relevant to cell-based assays. COAs for peptides intended for cell culture work should ideally specify whether a counter-ion exchange step (e.g., replacement with acetate) has been performed.
Solubility Recommendations
Some COAs include supplier-recommended solubility conditions based on peptide physicochemical properties. These are starting-point suggestions grounded in sequence analysis (charge, hydrophobicity index) rather than independently validated dissolution assays. Always perform your own solubility testing under your specific buffer and concentration conditions.
Storage Conditions and Shelf-Life Data
Peptide stability is sequence-dependent. COAs typically specify storage temperature (commonly −20 °C or −80 °C for longer-term storage), light sensitivity, and recommended atmosphere (desiccated, inert gas). Methionine, cysteine, and tryptophan residues are particularly susceptible to oxidation; peptides containing these residues may carry specific handling notes. Adhere to stated conditions; deviation can produce oxidized or aggregated species that alter experimental outcomes without producing obvious visual changes to the lyophilized material.
What a Strong COA Looks Like Versus a Weak One
A high-quality COA includes: a full sequence listing with explicit modifications; RP-HPLC chromatogram or area integration table with stated method parameters; ESI-MS or MALDI-TOF data with observed and theoretical masses; lot-specific purity value; storage and handling instructions; and supplier contact information for technical queries. Weak COAs list a purity percentage without supporting chromatographic evidence, omit mass spectrometry data, or carry generic (non-lot-specific) information suggesting template documents rather than actual QC data. If any of these elements are missing, request the underlying analytical data from your supplier before using the material in experiments where result validity depends on peptide identity and purity.
For research use only. The information presented in this article is intended solely for use by qualified laboratory researchers in non-clinical research settings. Research peptides supplied by Pepitiva Biolabs are not approved for, and are not intended for, any diagnostic, therapeutic, or human-use application.